AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts

robot
Abstract generation in progress

AtriCure, Inc. (NASDAQ:ATRC) has received an average rating of “Moderate Buy” from eleven research firms, with a consensus one-year price target of $48.43. While the company exceeded Q4 EPS estimates and saw revenue growth, it remains unprofitable. Recent insider selling and significant institutional ownership were also noted.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin